Public trial registry of the CCC-Munich

Trial AIO STO 0801

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AIO STO 0801
World
Full title
:

An Open Label Randomized Controlled Phase lI Trial of Panitumumab inCombination with Epirubicin, Cisplatin and Capecitabine (ECX) versus ECX Chemotherapy alone in Subjects with Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction.

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu
Indications
Classification Code Description
ICD-10-GM C16.- Bösartige Neubildung des Magens
Trial design
World
Phase
:
II
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Participants
Function Prename Surname Organization
World Responsible contact Volker Heinemann KUM - Med3 - Medizinische Klinik und Poliklinik III Magnifier
World Principal Investigator Volker Heinemann KUM - Med3 - Medizinische Klinik und Poliklinik III Magnifier
World Sponsor AIO-Studien gGmbH Magnifier